Synapse - Charlotte Ariyan

Results (51)

Telomerase reverse transcriptase (TERT) promoter mutations are associated with higher tumor mutational burden and UV mutational signature in melanoma

Meeting Abstract

Leinwand, J. C.; Koh, E.; Bartlett, E.; Bello, D.; Brady, M. S.; Harding, J. J.; Morris, L.; Ariyan, C.
Annals of Surgical Oncology (2024)

Fulltext@MSK | Save

Clinical utility of melanoma sentinel lymph node biopsy nomograms

Meeting Abstract

Drebin, H. M.; Hosein, S.; Kurtansky, N.; Moy, A. P.; Ariyan, C. E.; Bello, D. M.; Brady, M. S.; Coit, D. G.; Marchetti, M. A.; Bartlett, E. K.
Journal of the American College of Surgeons (2023)

Fulltext@MSK | Save

Interim results of a phase II trial of regional melphalan via limb infusion and systemic PD1 blockade in patients with extremity sarcoma

Meeting Abstract

Bartlett, E. K.; D'Angelo, S.; Kelly, C.; Rosenbaum, E.; Movva, S.; Erinjeri, J.; Fisher, C.; Singer, S.; Antonescu, C.; Ariyan, C.
Annals of Surgical Oncology (2023)

Fulltext@MSK | Save

A phase II study of talimogene laherparepvec (T-VEC) and pembrolizumab in patients with advanced sarcoma: Results of expansion cohorts

Meeting Abstract

Kelly, C. M.; Avutu, V.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; Movva, S.; Rosenbaum, E.; Cordover, E.; Ariyan, C. E.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

A phase II randomized trial of talimogene laherparepvec (T-VEC) oncolytic immunotherapy with or without radiotherapy for patients with cutaneous metastases from solid tumors

Meeting Abstract

Barker, C. A.; D'Angelo, S. P.; Steckler, A. M.; Lian, M.; Wasilewski, G.; Lacouture, M. E.; Chapman, P. B.; Shoushtari, A. N.; Ariyan, C. E.
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

In-transit melanoma: A multi-institutional analysis of outcomes

Meeting Abstract

Bello, D.; Rhodin, K. E.; Brady, M. S.; Bartlett, E.; Mosca, P.; Salama, A. K.; Tyler, D.; Ariyan, C.; Beasley, G.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Disease progression and trends in the management of in transit melanoma

Meeting Abstract

Rhodin, K. E.; Bello, D.; Farrow, N.; Mosca, P.; Salama, A. K.; Nair, S.; Tyler, D.; Ariyan, C.; Beasley, G.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

T-VEC treatment reverses PD-1 resistance by altering the microenvironment of tumors

Meeting Abstract

Theriot, J.; Hu, J.; Wong, R. J.; Wolchok, J.; Rudensky, A.; Ariyan, C.
Annals of Surgical Oncology (2022)

Fulltext@MSK | Save

Neoadjuvant and adjuvant nivolumab (nivo) with anti-LAG3 antibody relatlimab (rela) for patients (pts) with resectable clinical stage III melanoma